We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Collaboration for Cardiac CT Research

By HospiMedica staff writers
Posted on 27 Feb 2007
Toshiba America Medical Systems, Inc. More...
(Tustin, CA, USA; www.medical.toshiba.com) recently announced a multi-year, multi-system agreement with Brigham and Women's Hospital (BWH; Boston, MA, USA; www.brighamandwomens.org)--one of the top five cardiac hospitals in the United States and a leader in cutting-edge research activities.

As part of the agreement, BWH has installed Toshiba's Aquilion 64 CFX computed tomography (CT) system--the cardiac CT system currently under evaluation in the CorE64 clinical trial. The Aquilion CFX will play an important role in BWH's ongoing evaluation and validation of cardiac CT as a tool for diagnosing early stage heart disease without the use of interventional procedures that can cause greater risk for the patient.

"BHW is internationally known for its treatment of complex cardiac disorders, and our new Aquilion CFX will greatly improve our diagnostic and research capabilities moving forward,” said Dr. Frank J. Rybicki, M.D., Ph.D., director of the Applied Imaging Science Laboratory and co-director of the cardiovascular imaging section at BWH radiology. "The system's ability to deliver precise, 0.5 mm slices and its excellent low-contrast resolution will dramatically impact the advanced cardiovascular work we do-particularly in the areas of coronary remodeling, perfusion, and functional imaging.”

"The system will improve more than just our contributions to the cardiovascular sector,” said Steven Seltzer, chairman of the radiology department at BWH. "With Toshiba's technology, we now will be able to image other organs more precisely and provide better diagnoses for all of our patients.”

According to Doug Ryan, senior director of the CT Business Unit for Toshiba, "BWH's reputation as a leader in biomedical research makes this institution an ideal partner for validating the benefits of cardiac CT and expanding our research and development in other key clinical CT studies. The commitment by BWH to our current Aquilion 64 slice CT technology and their intention to expand this further to more advanced technologies is testimony to the clinical capabilities of the Aquilion CFX CT series.”


Related Links:
Toshiba America Medical Systems
Brigham and Women's Hospital

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Gold Member
UGPIV Barrier and Securement
UltraDrape II
Infant Resuscitator
Easypuff
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.